REFERENCES
  1. Wells D, Popish S, Kay C, Torrise V, Christopher M. VA Academic Detailing Service: Implementation and Lessons Learned. Fed Pract. 2016; May 33(5):38-42.
  2. Montano M, Bernardy NC, Sherrieb K. Cultivating change door to door: Educational outreach to improve prescribing practices in rural veterans with posttraumatic stress disorder. Sub Abuse, 2017;38:129-134.
  3. Program focuses on safe psychiatric medication. Department of Veterans Affairs (online). Available at www.blogs.va.gov/Vantage/27099/program-focuses-safe-psychiatric-medication. Accessed May 10, 2020.
  4. Psychotropic Drug Safety Initiative Dashboard Report: Internal VHA data from the Corporate Data Warehouse, analysis by the VA Office of Mental Health and Suicide Prevention. Accessed June 13, 2019.
  5. Lund BC, Bernardy NC, Alexander B, Friedman M. Declining benzodiazepine use in veterans with posttraumatic stress disorder. J Clin Psychiatry 2012;73:292-296.
  6. U.S. Department of Veterans Affairs, & U.S. Department of Defense. VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder.2017. Available at: https://www.healthquality.va.gov/guidelines/MH/ptsd/VADoDPTSDCPGFinal012418.pdf. Accessed March 1, 2020.
  7. Guina J, Rossetter SR, DeRhodes BJ, Nahhas RW, Welton RS. Benzodiazepines for PTSD: A systematic review and meta-analysis. J Psychiatr Pract 2015; 21:281-303.
  8. National Center for Veterans Analysis & Statistics. Veterans population projection model FY17. 2017; Veterans Health Administration.
  9. Penninkilampi R, Eslick GD. A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias. CNS Drugs, 2018; 32:485-497.
  10. Yaffe K, Vittinghoff E, Lindquist K, et al. Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry, 2010;67:608-613.
  11. Obiora E, Hubbard R, Sanders RD, Myles PR. The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: A nested case-control and survival analysis in a population-based cohort. Thorax. 2013;68:163-170.
  12. Agarwal SD, Landon BE. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Network Open, 2019;2:e187399.
  13. Cook JM, Marshall R, Masci C, Coyne JC. Physicians’ perspectives on prescribing benzodiazepines for older adults: A qualitative study. J Gen Intern Med 2007;22:303-307.
  14. Jessell L, Stanhope V, Manuel J, Mateu-Gelabert P. Factors associated with benzodiazepine prescribing in community mental health settings. Jrl of Sub Abuse Treatment 2020;109:56-60.
  15. Lund BC, Abrams TE, Bernardy NC, Alexander B, Friedman M. Benzodiazepine prescribing variation and clinical uncertainty in treating posttraumatic stress disorder. Psychiatr Serv, 2013:64(1):21-27.
  16. Parker LE, Ritchie MJ, Kirchner JE, Owen RR. Balancing health care evidence and art to meet clinical needs: Policymakers’ perspectives. J Eval Clin Pract 2009;15:970-975.
  17. Karel MJ, Wray LO, Adler G, et al. Mental health needs of aging veterans: Recent evidence and clinical recommendations. Clin Ger 2020, online 23 Jan.
  18. Deka R, Bryan CJ, LaFleur J, Oderda G, Atherton A, Stevens V. Benzodiazepines, healthcare utilization, and suicidal behavior in veterans with posttraumatic stress disorder. J Clin Psychiatry 2018;79(6):17m12038.
  19. National Institute for Health and Clinical Excellence. Management of anxiety (panic disorder with or without agoraphobia, and generalized anxiety disorder) in adults in primary, secondary and community care. London: NICE guidelines 2004 (amended 2007). http://www.nice.org.uk/Guidance/CG22.
  20. Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med, 2016;165,2:125-133.
  21. Barnett ER, Bernardy NC, Jenkyn AB, et al. Prescribing clinicians’ perspectives on evidence-based psychotherapy for posttraumatic stress disorder. Behav Sci, 2014;4:410-422.
  22. Abrams TE, Lund BC, Bernardy NC, et al. Aligning clinical practice to PTSD treatment guidelines: Medication prescribing by provider type. Psychiatr Serv, 2013;64:142-148.
  23. Mendes MA, Smith JP, Marin JK, et al., Reducing benzodiazepine prescribing in older veterans: A direct-to-consumer educational brochure. Fed Pract, 2018;35:36-43.
  24. Bernardy NC, Montano M, Cuccurrullo LA, Breen K, Cole, B. Taking the message to the rural patient: Evidence-based PTSD care. Jrl of Beh Med, In press.
  25. Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Intern Med., 2014;174(6):890-898.
  26. Benzodiazepines and PTSD [VA PTSD website], Available at https://www.ptsd.va.gov/understand_tx/benzos_ptsd.asp. Accessed August 15, 2020.
27. Morin CM, Bastien C, Guay B, et al. Randomized clinical trial of supervised tapering and cognitive behavioral therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry, 2004;161:332-342.